I have been a long term critic of both Hemogenyx (HEMO) and of its directors, the pompous arse Vlad Sandler and 214 year old Peter Redmond. The shares were pumped to highs of 1153p earlier thus year allowing a funding at 800p. But I’ve been doing the Winni-maths and Vlad and Pete (should that be Pete & Dud*?) should SMTM, or rather lack of it and ‘fess up to when the next placing is needed.
Hemogenyx (HEMO) has today served up more ramptastic news from the Baltic states and updated us on the pedestrian pace of its phase 1 drug trials. There is a killer phrase buried at the bottom of the release. First do the maths.
The share price action tells you that today’s RNS about a £3 million fund raise at 801p from Hemogenyx (HEMO) is just complete cock. The scallways ay Nomad SP Angel and brokers AlbR should be thoroughly ashamed of having their names attached to it.
With just three patients in phase 1 trials Hemogenyx (HEMO) is at an incredibly early stage of drug development. But at least it is doing something, until recently it has just been a lifestyle business for its cock of a CEO Vlad Sandler. Today a prospectus is out, allowing yet more confetti to start trading. Turn to page 7
The maths really are not that hard. Dianne Abbott could do them. Okay I exaggerate she could not. But the thesis stands. Just look at results for lifestyle pretend biotech company Hemogenyx (HEMO) for the six months to June 30.
If anyone knows where I can get some borrow on Hemogenyx Pharmaceuticals (HEMO) then please post below. A friend told me on Friday evening that he had managed to short some with IG and so first thing this morning I got in touch with my relationship manager there - but it had all gone! I can understand why the borrow is so hard to get as lots of people want to short the shares, what I can’t understand is the sheer stupidity of those people that are buying the shares!
It is hard to know where to start with this charmer who appears to have 0 followers on X. He is deranged as you can see with two tweets from last night.
With a hap tip to readers T and K the details of the US phase 1 trial of Hemogenyx’s (HEMO) AML drug can now be revealed and it is not good news for deluded fools like Christopher Kilner who own the shares. Oh no…
What would Mr Kilner’s partner or employer think if they saw how he stays up late at night posting vile and defamatory comments as Pingu777 on the LSE Asylum?
Yesterday Hemogenyx (HEMO) announced that it had signed a letter of intent with Cellin Technologies OU in Estonia claiming that this “represents the first near term revenue opportunity.” Let me and also a qualified doctor with expertise in clinical trials, explain why that is just Vlad Sandler over-egging the pudding big time.. And why that ultimately consigns all involved in this spoof to a special place in hell.
Fitzpatrick featured here a few days ago with his limp dick website dedicated to ramping Hemogenyx (HEMO). Now this obvious obsessive has spent the morning trolling me on twitter and making himself look ever more of a congenital idiot with each tweet as you can see below.
Apparently according to twitter fucktard Gavin Fitzpatrick my commentary about Hemogenyx (HEMO) is because I have a “grudge” which explains why I have ignored so many obvious frauds just to obsess constantly about this one company. Gavin admits to not reading any of my articles but knows they are all wrong. Next he will be lambasting me or either batting for cancer or for trying to take down another “great British company” becuase i am eiher a Mossad agent or a Russian asset. Or both. This brings me to today’s tie up in Estonia showing what a small world we live in.
Actually it is an academic who has a long history in clinical trial data supervision and whose work in exposing malpractice has featured, inter alia, in Private Eye. The company in question is Hemogenyx (HEMO) where I think I owe it a minor apology but it owes Mr. Market an even greater one
I was promised an imminent update of the health status of patients 1 and 2 by an advisor to overpromoted box of snakes shitco Hemogenyx (HEMO) two days ago. I have heard nothing which makes me fear for their health. They will be in my prayers tonight since had they been running half marathons I would have had a speedy response saying just that. And this silence, as I explained HERE, should make shareholders run for the hills.
Shares in the worthless lifestyle company Hemogenyx (HEMO) have raced ahead by 68% today to 316p after a placing raising gross proceeds of £570,000 at 180p was announced yesterday. Lets call it £520,000 net and that tells you that ghastly boss Vald Sandler will be passing the hat around yet again before Christmas.
It was running on vapours so it’s no shock that Hemogenyx (HEMO), the pointless main market listed lifestyle company run by pompous prick Vlad Sandler has placed yet again, raising £451,000 gross at 180.5p. That will keep the wolf from the door for a couple of months by when Vlad will have to do another funding. But this one stinks, the RNS looks like its a lie.
I have been a perma bear of Hemogenyx (HEMO) flagging up pig and pork fund raisings, outrageous claims of progress that cannot be justified, executive greed and more. But for some reason I missed yesterday’s calendar 2024 results. Luckily Liverpool’s greatest numbers man since Ken Dodd is on the case and flags up what a total horror show this is. Evil Banksta opines:
Frances Farmer uses the sort of language that would make the late Bernard Manning blush over on X, formerly twitter. I have no idea who Frances is but he/she/they have launched a mini tirade against either myself or the arsehole boss of Hemogenyx (HEMO), Vlad Sandler.
Once again, I brace myself to be accused of batting for team leukemia for having the nerve to point out bad things at Hemogenyx (HEMO). The reality is that it is Hemogenyx and its boss, Vlad Sandler, on £400,000+ a year, who are acting in an unethical way.
